HCW Biologics (HCWB) Gross Profit (2022 - 2025)

HCW Biologics (HCWB) has 4 years of Gross Profit data on file, last reported at $5401.0 in Q4 2025.

• Quarterly Gross Profit fell 93.16% year-over-year to $5401.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10845.0 (down 98.87% YoY) and the FY2025 annual result came in at $10846.0, down 98.87% from the prior year.
• Gross Profit grew to $5401.0 in Q4 2025, from $3121.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $1.8 million in Q1 2022 to a low of $1013.0 in Q1 2025.
• A 4-year average of $257311.7 and a median of $143602.5 in 2022 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2024 — Gross Profit jumped 4805.03% — and 2025, when it tumbled 99.84%.
• Tracing HCWB's Gross Profit over 4 years: stood at $268304.0 in 2022, then fell by 5.84% to $252645.0 in 2023, then slumped by 68.75% to $78961.0 in 2024, then sank by 93.16% to $5401.0 in 2025.
• The last three Gross Profit figures came in at $5401.0 (Q4 2025), $3121.0 (Q3 2025), and $1310.0 (Q2 2025), per Business Quant data.